Skip to main content

Table 2 Prevalence of metabolic syndrome according to different diagnostic definitions

From: Prevalence of metabolic syndrome among breast cancer survivors in East Coast of Peninsular Malaysia

MetS diagnostic definition All (n = 95)
n (%)
95% Confidence Interval
Harmonized (2009) 48 (50.5) 40.6–60.3
IDF (2005) 46 (48.4) 38.6–58.3
NCEP ATP III (2001) 38 (40.0) 30.7–50.0
WHO (1999) 18 (18.9) 12.3–27.9
  1. IDF International Diabetes Federation, MetS Metabolic syndrome, NCEP ATP III National Cholesterol Education Program Adult Treatment Panel III, WHO World Health Organization